BWL
MRNA icon

Bogart Wealth LLC’s Moderna MRNA Stock Holding History

Bogart Wealth LLC’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.6K Sell
437
-2
-0.5% -$103 ﹤0.01% 670
2026
Q1 		$22.3K Buy
439
+39
+10% +$1.82K ﹤0.01% 694
2025
Q4 		$11.8K Sell
400
-38
-9% -$1.03K ﹤0.01% 828
2025
Q3 		$11.3K Buy
438
+2
+0.5% +$56 ﹤0.01% 806
2025
Q2 		$12K Buy
436
+36
+9% +$948 ﹤0.01% 756
2025
Q1 		$11.3K Buy
400
+293
+274% +$10.4K ﹤0.01% 720
2024
Q4 		$4.45K Sell
107
-20
-16% -$956 ﹤0.01% 909
2024
Q3 		$8.49K Hold
127
– – ﹤0.01% 732
2024
Q2 		$15.1K Buy
127
+7
+6% +$886 ﹤0.01% 584
2024
Q1 		$12.8K Buy
120
+5
+4% +$504 ﹤0.01% 601
2023
Q4 		$11.4K Hold
115
– – ﹤0.01% 598
2023
Q3 		$11.9K Hold
115
– – ﹤0.01% 561
2023
Q2 		$14K Hold
115
– – ﹤0.01% 526
2023
Q1 		$17.7K Sell
115
-20
-15% -$3.3K ﹤0.01% 481
2022
Q4 		$24.2K Sell
135
-50
-27% -$8.18K ﹤0.01% 403
2022
Q3 		$22K Buy
185
+70
+61% +$10.6K ﹤0.01% 416
2022
Q2 		$16K Sell
115
-20
-15% -$2.86K ﹤0.01% 455
2022
Q1 		$23K Sell
135
-15
-10% -$2.52K ﹤0.01% 364
2021
Q4 		$38K Sell
150
-5
-3% -$1.46K ﹤0.01% 294
2021
Q3 		$60K Hold
155
– – 0.01% 234
2021
Q2 		$36K Sell
155
-1,975
-93% -$353K ﹤0.01% 270
2021
Q1 		$279K Buy
2,130
+2,110
+10,550% +$306K 0.04% 126
2020
Q4 		$2K Buy
+20
New +$2.02K ﹤0.01% 407
2020
Q3 		– Sell
-100
Closed -$6K – 471
2020
Q2 		$6K Buy
+100
New +$5.48K ﹤0.01% 335

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Bogart Wealth LLC's MRNA Position: Q2 2026 in Review

Bogart Wealth LLC reduced its Moderna (MRNA) stake by 0.46% in Q2 2026, selling an estimated $103 and leaving 437 shares worth $30.6K. The position accounts for ﹤0.01% of the portfolio, ranked #670.

Bogart Wealth LLC first reported a position in MRNA in Q2 2020 and has held it in 24 quarters since. The position peaked at $279K in Q1 2021. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Bogart Wealth LLC held 437 shares of Moderna worth $30.6K as of Q2 2026.
  • Bogart Wealth LLC sold 2 Moderna shares in Q2 2026, an estimated $103.
  • Moderna made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q2 2026, its #670 holding.
  • Bogart Wealth LLC first reported a position in Moderna in Q2 2020 and has held it in 24 quarters since.
  • Bogart Wealth LLC's Moderna position peaked at $279K in Q1 2021.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Bogart Wealth LLC's 13F filing for Q2 2026, filed 24 Jul 2026.